Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Sipavibart (AZD-3152), a COVID-19 Pre-Exposure Prophylaxis in Myeloma Treated with BCMA/CD3 Bispecific Antibodies

Helene Gardeney, Arthur Bobin, Jean-Marc Gombert, Andre Herbelin, Cecile Tomowiak, Elodie Dindinaud, Caroline Basle, Laly Nsiala, Laura Cailly, Mathilde Vonfeld, Aurelia Chacon, Aurelien Pichon, Thomas Lombard, Isabelle Princet, Nicolas Leveque, Xavier Leleu, Thomas Systchenko

Blood (2024) 144 (Supplement 1): 7222.

https://doi.org/10.1182/blood-2024-208428

Published: 2024

Journal Articles

NK Cells and KIR+ / NKG2A+ Innate like CD8+ T Lymphocytes Features in the Bone Marrow of Multiple Myeloma Patients

Helene Gardeney, Emma Narbeburu, Alice Barbarin, Niels Moya, Arthur Bobin, Anthony Levy, Cecile Gruchet, Xavier Leleu, Andre Herbelin, Jean-Marc Gombert

Blood (2024) 144 (Supplement 1): 6865.

https://doi.org/10.1182/blood-2024-208578

Published: 2024

Journal Articles

Implication of STAT-5 Recruitment in the Expression of IRF-8 and in the Impairment of Human Plasmacytoid Dendritic Cells Differentiation Induced by BCR-ABL and GM-CSF

Anne Barra, PhD, Lucie Brault, Ali G Turhan, M.D., PhD, Lydia Roy, MD, PhD, François Guilhot, Jean-Marc Gombert, M.D., PhD

Blood (2008) 112 (11): 3196.

https://doi.org/10.1182/blood.V112.11.3196.3196

Published: 2008

Journal Articles

Functional Alterations of NKT Cells in Chronic Myeloid Leukemia Patients Can Be Reversed by Imatinib Mesylate In Vitro.

Alexis Rossignol, Anne Barra, Francois Guilhot, Ali G. Turhan, Jean-Marc Gombert

Blood (2006) 108 (11): 2128.

https://doi.org/10.1182/blood.V108.11.2128.2128

Published: 2006

Journal Articles

Depletion of Circulating Plasmacytoid Dendritic Cells in Chronic Myelogenous Leukemia and Their Restoration after Interferon-alpha or Imatinib Mesylate.

Alexis Rossignol, Anne Barra, Lydia Roy, Francois Guilhot, Ali G. Turhan, Jean-Marc Gombert

Blood (2006) 108 (11): 2204.

https://doi.org/10.1182/blood.V108.11.2204.2204

Published: 2006

NARROW

Sipavibart (AZD-3152), a COVID-19 Pre-Exposure Prophylaxis in Myeloma Treated with BCMA/CD3 Bispecific Antibodies

NK Cells and KIR+ / NKG2A+ Innate like CD8+ T Lymphocytes Features in the Bone Marrow of Multiple Myeloma Patients

Implication of STAT-5 Recruitment in the Expression of IRF-8 and in the Impairment of Human Plasmacytoid Dendritic Cells Differentiation Induced by BCR-ABL and GM-CSF

Functional Alterations of NKT Cells in Chronic Myeloid Leukemia Patients Can Be Reversed by Imatinib Mesylate In Vitro.

Depletion of Circulating Plasmacytoid Dendritic Cells in Chronic Myelogenous Leukemia and Their Restoration after Interferon-alpha or Imatinib Mesylate.

Email alerts

ASH Publications

American Society of Hematology

Sipavibart (AZD-3152), a COVID-19 Pre-Exposure Prophylaxis in Myeloma Treated with BCMA/CD3 Bispecific Antibodies

NK Cells and KIR+ / NKG2A+ Innate like CD8+ T Lymphocytes Features in the Bone Marrow of Multiple Myeloma Patients

Implication of STAT-5 Recruitment in the Expression of IRF-8 and in the Impairment of Human Plasmacytoid Dendritic Cells Differentiation Induced by BCR-ABL and GM-CSF

Functional Alterations of NKT Cells in Chronic Myeloid Leukemia Patients Can Be Reversed by Imatinib Mesylate In Vitro.

Depletion of Circulating Plasmacytoid Dendritic Cells in Chronic Myelogenous Leukemia and Their Restoration after Interferon-alpha or Imatinib Mesylate.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only